- Home
- CVAC vs SSYS Comparison
CVAC vs SSYS Comparison
Compare CVAC & SSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- SSYS
- Stock Information
- Founded
- CVAC 2000
- SSYS 1989
- Country
- CVAC Germany
- SSYS United States
- Employees
- CVAC N/A
- SSYS N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- SSYS Computer peripheral equipment
- Sector
- CVAC Health Care
- SSYS Technology
- Exchange
- CVAC Nasdaq
- SSYS Nasdaq
- Market Cap
- CVAC 764.4M
- SSYS 857.2M
- IPO Year
- CVAC 2020
- SSYS 1994
- Fundamental
- Price
- CVAC $5.45
- SSYS $11.69
- Analyst Decision
- CVAC Hold
- SSYS Strong Buy
- Analyst Count
- CVAC 3
- SSYS 4
- Target Price
- CVAC $6.83
- SSYS $12.50
- AVG Volume (30 Days)
- CVAC 2.2M
- SSYS 408.7K
- Earning Date
- CVAC 08-14-2025
- SSYS 08-28-2025
- Dividend Yield
- CVAC N/A
- SSYS N/A
- EPS Growth
- CVAC N/A
- SSYS N/A
- EPS
- CVAC 0.87
- SSYS N/A
- Revenue
- CVAC $566,039,775.00
- SSYS $564,454,000.00
- Revenue This Year
- CVAC N/A
- SSYS $2.01
- Revenue Next Year
- CVAC $24.04
- SSYS $4.01
- P/E Ratio
- CVAC $6.31
- SSYS N/A
- Revenue Growth
- CVAC 787.60
- SSYS N/A
- 52 Week Low
- CVAC $2.37
- SSYS $6.05
- 52 Week High
- CVAC $5.72
- SSYS $12.88
- Technical
- Relative Strength Index (RSI)
- CVAC 65.07
- SSYS 65.39
- Support Level
- CVAC $5.36
- SSYS $10.63
- Resistance Level
- CVAC $5.45
- SSYS $11.90
- Average True Range (ATR)
- CVAC 0.08
- SSYS 0.33
- MACD
- CVAC -0.05
- SSYS 0.07
- Stochastic Oscillator
- CVAC 58.00
- SSYS 82.63
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About SSYS Stratasys Ltd. (Israel)
Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.